Bioprosthetics Market: Global Industry Analysis and Forecast (2023-2029)

Bioprosthetics Market is expected to reach US$ 10.49 Bn. at a CAGR of 10.3% during the forecast period 2029.

Bioprosthetics Market Overview:

The Bioprosthetics is an implantable device, which is originated from non-synthetic or natural source. Many advantages are associated with the use of bioprostheses, owing to their basic characteristic as they become degraded until their complete elimination in the host body.Bioprosthetics MarketTo know about the Research Methodology :- Request Free Sample Report

Bioprosthetics Market Dynamics:

Increasing demand for technologically advanced products providing long term relief will rapidly drive the market growth. Rising patient pool suffering from cardiovascular diseases such as rheumatic heart diseases in which valve replacement is necessary will raise the demand for the Bioprosthetics market. The rising rate of cardiovascular diseases is attributed due to an unprecedented shift in lifestyle habits. It was estimated that the global prevalence of rheumatic heart disease surpassed 33.4 million in 2015 and is still observed to be increasing in upcoming years. Along with this, a rise in the geriatric population with cardiovascular diseases and respiratory diseases is anticipated to propel the market growth. Rapid innovations in the tissue-engineered bioprostheses will bolster the market growth. The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Bioprosthetics Market Segment Analysis:

The global Bioprosthetics market is segmented on the basis of type and application and Product. Based on the Type, the Xenograft segment held a significant share of xx% in 2022. Xenograft is the transplanted tissues across a species barrier that is from one type of species to other. The segment is anticipated to grow during forecast years owing to its widespread application as it has been extensively used as scaffolds for multiple cardiac tissue types engineering, surgical management of burn wounds, etc. Numerous benefits associated with xenografting like long term stability, ease of availability of raw materials, high survival rates, low manufacturing costs and easy implantation procedures make it a suitable choice amongst available Bioprosthetics, which in turn potentially drive the segment growth. Based on the Application, the cardiovascular segment is expected to dominate the global market owing to rising cases of cardiovascular surgeries requiring valve replacements. Bioprosthetic heart valves (BHVs) are constructed from porcine heart valves or bovine pericardium preserved with glutaraldehyde. Patients with BHVs do not require anticoagulation. Moreover, increased usage of minimally invasive surgical procedures using second-generation Bioprosthetics, which aim at reducing structural failures is the main factor contributing to the rising demand for bio-implants during the forecast period. The development of Bioprosthetic Heart Valves has led to the reduction of open-heart surgeries which crucially contributes to the dominant share of the segment. Bioprosthetics Market Regional Insights: Europe held a dominant market share of xx% in 2022 and is expected to continue the dominance throughout forecast period. Increasing incidences of cardiovascular diseases in the region and technological advancements in the field of Bioprosthetics primarily drive the market growth. Each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). In April 2017, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe. APAC region is estimated to grow at a faster pace during forecast period, by registering a CAGR of xx%. Rapidly improving healthcare infrastructure, reimbursement policies, easily accessible healthcare facilities and patient’s awareness will primarily contribute to the market growth. Ongoing research and development activities in the emerging economies like India, China will majorly contribute to the market growth in the region. The report also helps in understanding Global Bioprosthetics Market dynamics, structure by analyzing the market segments and project the Global Bioprosthetics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Bioprosthetics Market make the report investor’s guide.

Bioprosthetic Market Scope: Inquire before buying

Global Bioprosthetic Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 5.28 Bn.
Forecast Period 2022 to 2029 CAGR: 10.3% Market Size in 2029: US $ 10.49 Bn.
Segments Covered: by Type Xenograft Allograft
by Application Cardiovascular Nephrological Orthopedics Neurological Ophthalmic Urogenital
by Product Mechanical Heart Valve Tissue Heart Valve Stented Tissue Heart Valve Stentless Tissue Heart Valve Transcatheter Heart Valve

Bioprosthetics Market, by Region:

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Bioprosthetics Market Key Players are:

1. Life Cell Corporation 2. Edwards Lifesciences Corporation 3. LeMaitre Vascular, Inc. 4. CryoLife, Inc. 5. Labcor Laboratorios Ltd. 6. Maquet Metinge Group 7. Organogenesis, Inc. 8. Braile Biomedica, Inc. 9. Medtronic Plc. 10.Humacyte, Inc. 11.Aortech International Plc 12.JenaValve Technology GmbH 13.Sorin Group 14.Ethicon, Inc. 15.St. Jude Medical, Inc.

Frequently Asked questions

1. What is the market size of the Global Bioprosthetic Market in 2022? Ans. The market size Global Bioprosthetic Market in 2022 was US$ 5.28 Billion. 2. What are the different segments of the Global Bioprosthetic Market? Ans. The Global Bioprosthetic Market  is divided into Application, Product and Type. 3. What is the study period of this market? Ans. The Global Bioprosthetic Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Bioprosthetic Market share? Ans. The Asia Pacific dominates the market share in the  market. 5. What  is the Forecast Period of Global Bioprosthetic Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
1. Global Bioprosthetics Market: Research Methodology 2. Global Bioprosthetics Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Bioprosthetics Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Bioprosthetics Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Bioprosthetics Market Segmentation 4.1 Global Bioprosthetics Market, by Product (2022-2029) • Xenograft • Allograft 4.2 Global Bioprosthetics Market, by Application (2022-2029) • Cardiovascular • Nephrological •Orthopedics • Neurological • Ophthalmic •Urogenital 4.3 Global Bioprosthetics Market, by Product (2022-2029) • Mechanical Heart Valve • Tissue Heart Valve • Stented Tissue Heart Valve • Stentless Tissue Heart Valve • Transcatheter Heart Valve 5. North America Bioprosthetics Market(2022-2029) 5.1 North America Bioprosthetics Market, by Product (2022-2029) 4.1 Global Bioprosthetics  Market, by Product (2022-2029) • Xenograft • Allograft 5.2 North America Bioprosthetics Market, by Application (2022-2029) • Cardiovascular • Nephrological •Orthopedics • Neurological • Ophthalmic •Urogenital 5.3 North America Bioprosthetics Market, by Product (2022-2029) • Mechanical Heart Valve • Tissue Heart Valve • Stented Tissue Heart Valve • Stentless Tissue Heart Valve • Transcatheter Heart Valve 5.4 North America Bioprosthetics Market, by Country (2022-2029) • United States • Canada • Mexico 6. Europe Bioprosthetics Market (2022-2029) 6.1. European Bioprosthetics Market, by Product (2022-2029) 6.2. European Bioprosthetics Market, by Application (2022-2029) 6.3. European Bioprosthetics Market, by Product (2022-2029) 6.4. European Bioprosthetics Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Bioprosthetics Market (2022-2029) 7.1. Asia Pacific Bioprosthetics Market, by Product (2022-2029) 7.2. Asia Pacific Bioprosthetics Market, by Application (2022-2029) 7.3. Asia Pacific Bioprosthetics Market, by Product (2022-2029) 7.4. Asia Pacific Bioprosthetics Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Bioprosthetics Market (2022-2029) 8.1 Middle East and Africa Bioprosthetics Market, by Product (2022-2029) 8.2. Middle East and Africa Bioprosthetics Market, by Application (2022-2029) 8.3. Middle East and Africa Bioprosthetics Market, by Product (2022-2029) 8.4. Middle East and Africa Bioprosthetics Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Bioprosthetics Market (2022-2029) 9.1. South America Bioprosthetics Market, by Product (2022-2029) 9.2. South America Bioprosthetics Market, by Application (2022-2029) 9.3. South America Bioprosthetics Market, by Product (2022-2029) 9.4 South America Bioprosthetics Market, by Country (2022-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Life Cell Corporation 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Edwards Lifesciences Corporation 10.3 LeMaitre Vascular, Inc. 10.4 CryoLife, Inc. 10.5 Labcor Laboratorios Ltd. 10.6 Maquet Metinge Group 10.7 Organogenesis, Inc. 10.8 Braile Biomedica, Inc. 10.9 Medtronic Plc. 10.10 Humacyte, Inc. 10.11 Aortech International Plc 10.12 JenaValve Technology GmbH 10.13 Sorin Group 10.14 Ethicon, Inc. 10.15 St. Jude Medical, Inc.